Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Consensus and Guidelines · March 15, 2022

Risk of Infections Associated With MS and Neuromyelitis Optica Spectrum Disorder Disease-Modifying Treatments

Multiple Sclerosis (Houndmills, Basingstoke, England)


Additional Info

Disclosure statements are available on the authors' profiles:

Multiple Sclerosis (Houndmills, Basingstoke, England)
The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021
Mult. Scler. 2022 Feb 23;[EPub Ahead of Print], C Tur, AL Dubessy, S Otero-Romero, MP Amato, T Derfuss, F Di Pauli, E Iacobaeus, M Mycko, H Abboud, A Achiron, A Bellinvia, A Boyko, JL Casanova, D Clifford, R Dobson, MF Farez, M Filippi, KC Fitzgerald, M Fonderico, R Gouider, Y Hacohen, K Hellwig, B Hemmer, L Kappos, F Ladeira, C Lebrun-Frénay, C Louapre, M Magyari, M Mehling, C Oreja-Guevara, L Pandit, C Papeix, F Piehl, E Portaccio, I Ruiz-Camps, K Selmaj, S Simpson-Yap, A Siva, PS Sorensen, MP Sormani, M Trojano, A Vaknin-Dembinsky, S Vukusic, B Weinshenker, H Wiendl, A Winkelmann, MI Zuluaga Rodas, M Tintoré, B Stankoff

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading